We are live on !
Find out more
NED
Nancy E. Dempze Portfolio holdings
AUM
$209M
Turnover
11.34%
1-Year Est. Return
33.81%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+33.81%
3 Year Est. Return
+83.09%
5 Year Est. Return
+106.57%
10 Year Est. Return
+388.31%
AUM
$52M
AUM Growth
–
Cap. Flow
+$52.2M
Cap. Flow % of AUM
Cap. Flow %
100.46%
Top 10 Holdings %
Top 10 Hldgs %
31.32%
Holding
82
New
82
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.22M |
| 2 |
Automatic Data Processing
ADP
|
+$1.95M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.87M |
| 4 |
Mastercard
MA
|
+$1.6M |
| 5 |
3M
MMM
|
+$1.52M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.84% |
| 2 | Technology | 18% |
| 3 | Miscellaneous | 15.91% |
| 4 | Industrials | 12.72% |
| 5 | Consumer Staples | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
CVS Health
CVS
$115B
| $2.22M | 4.27% |
+22,715
| New | +$2.22M |
2015 Q4
0 quarters
|
|
|
2
Automatic Data Processing
ADP
$116B
| $1.92M | 3.68% |
+22,615
| New | +$1.95M |
2015 Q4
0 quarters
|
|
|
3
Johnson & Johnson
JNJ
$658B
| $1.91M | 3.67% |
+18,565
| New | +$1.87M |
2015 Q4
0 quarters
|
|
|
4
Mastercard
MA
$556B
| $1.59M | 3.06% |
+16,345
| New | +$1.6M |
2015 Q4
0 quarters
|
|
|
5
3M
MMM
$89.9B
| $1.49M | 2.87% |
+11,840
| New | +$1.52M |
2015 Q4
0 quarters
|
|
6
Procter & Gamble
PG
$374B
| $1.45M | 2.79% |
+18,280
| New | +$1.4M |
2015 Q4
0 quarters
|
|
7
AptarGroup
ATR
$8.7B
| $1.36M | 2.61% |
+18,665
| New | +$1.35M |
2015 Q4
0 quarters
|
|
8
Apple
AAPL
$5.03T
| $1.22M | 2.34% |
+46,208
| New | +$1.32M |
2015 Q4
0 quarters
|
|
9
Alphabet (Google) Class A
GOOGL
$3.44T
| $1.21M | 2.32% |
+31,000
| New | +$1.15M |
2015 Q4
0 quarters
|
|
10
Fiserv Inc
FISV
$26.6B
| $1.17M | 2.26% |
+25,600
| New | +$1.2M |
2015 Q4
0 quarters
|
|
11
PepsiCo
PEP
$187B
| $1.15M | 2.22% |
+11,540
| New | +$1.15M |
2015 Q4
0 quarters
|
|
12
Novartis
NVS
$304B
| $1.11M | 2.14% |
+14,437
| New | +$1.15M |
2015 Q4
0 quarters
|
|
13
Canadian National Railway
CNI
$74.2B
| $1.01M | 1.94% |
+18,062
| New | +$1.06M |
2015 Q4
0 quarters
|
|
14
Abbott
ABT
$184B
| $961K | 1.85% |
+21,400
| New | +$945K |
2015 Q4
0 quarters
|
|
15
Unilever
UL
$141B
| $934K | 1.8% |
+19,258
| New | +$940K |
2015 Q4
0 quarters
|
|
16
RTX Corp
RTX
$270B
| $875K | 1.68% |
+14,477
| New | +$876K |
2015 Q4
0 quarters
|
|
17
SLB Ltd
SLB
$79.3B
| $841K | 1.62% |
+12,040
| New | +$902K |
2015 Q4
0 quarters
|
|
18
Intel
INTC
$350B
| $828K | 1.59% |
+24,035
| New | +$812K |
2015 Q4
0 quarters
|
|
19
Chubb
CB
$139B
| $798K | 1.54% |
+6,828
| New | +$773K |
2015 Q4
0 quarters
|
|
20
Johnson Controls International
JCI
$90.3B
| $758K | 1.46% |
+18,319
| New | +$829K |
2015 Q4
0 quarters
|
|
21
Home Depot
HD
$328B
| $746K | 1.44% |
+5,640
| New | +$718K |
2015 Q4
0 quarters
|
|
22
Merck
MRK
$369B
| $675K | 1.3% |
+13,397
| New | +$675K |
2015 Q4
0 quarters
|
|
23
Walt Disney
DIS
$192B
| $670K | 1.29% |
+6,368
| New | +$710K |
2015 Q4
0 quarters
|
|
24
Oracle
ORCL
$396B
| $670K | 1.29% |
+18,356
| New | +$701K |
2015 Q4
0 quarters
|
|
25
Microsoft
MSFT
$3.88T
| $637K | 1.23% |
+11,488
| New | +$605K |
2015 Q4
0 quarters
|
|
Similar funds
HFS
IF
Nancy E. Dempze's Q4 2015 Portfolio in Review
Q4 2015 is the first quarter with a 13F filing on record for Nancy E. Dempze, which disclosed 82 positions worth $52M. Its ten largest holdings account for 31% of the portfolio.
Its largest position is CVS Health: 22,715 shares worth $2.22M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Technology and Miscellaneous.
- Nancy E. Dempze's largest Q4 2015 buy was CVS Health: 22,715 shares worth $2.22M.
- Nancy E. Dempze's ten largest holdings make up 31% of its $52M portfolio in Q4 2015.
- Nancy E. Dempze disclosed 82 positions in Q4 2015, its first 13F filing on record.
Based on Nancy E. Dempze's 13F filing for Q4 2015, filed 12 Feb 2016.